Both in Pharmaceuticals
Axsome Therapeutics vs Alkermes
Over the past year AXSM returned +7.0% and ALKS returned +47.7%; their daily moves had a correlation of 0.31.
AXSM +7.0% ALKS +47.7%Growth of $1, one year, split-adjusted
| Metric | AXSM | ALKS |
|---|---|---|
| Price | $144.43 | $45.34 |
| Market cap | $7.57B | $7.61B |
| Today | +0.68% | −0.07% |
| 1 month | −20.7% | +11.8% |
| 6 months | −30.1% | +35.8% |
| Year to date | −20.9% | +62.0% |
| 1 year | +8.3% | +44.2% |
| Revenue growth (YoY) | +45.5% | +27.0% |
| Gross margin | 93.8% | 80.2% |
| Net margin | −23.5% | 0.1% |
| P/E (TTM) | — | 115.0× |
| Price / sales | 9.7× | 4.6× |
| Net cash | $122.9M | -$846.5M |
| Dividend yield | — | — |
| Volatility (60d) | 37.2% | 31.7% |
| Short % of float | 7.6% | 11.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).